Trial intelligence / Profile preview

Azithromycin and levamisole in inflammatory acne vulgaris

NCT01348321Phase 3Completed

Sponsor
Ahvaz Jundishapur University of Medical Sciences
Start
Nov 2008
Primary completion
Oct 2009
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, single-blind trial of levamisole in acne vulgaris, sponsored by Ahvaz Jundishapur University of Medical Sciences. Primary endpoint: Number of Participants with Adverse Events at 1 year. Started Nov 2008; status: completed.

02

Drugs

levamisole
03

Conditions

acne vulgaris

Beyond the preview

Go deeper on NCT01348321.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01348321.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call